Haas, M <br/><br/>
Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease.  [electronic resource] 

 -  Kidney & blood pressure research  1998 
 - 66-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1420-4096 
<br/><br/><label>Standard No.: </label>10.1159/000025845  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Creatinine--metabolism<br/>DNA--analysis<br/>Enalapril--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Hemodynamics--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Peptidyl-Dipeptidase A--drug effects<br/>Polymerase Chain Reaction<br/>Polymorphism, Genetic<br/>Prospective Studies<br/>Proteinuria--drug therapy<br/>Sodium--urine<br/>Treatment Outcome